Progression-Free Survival and Local Control After SABR for up to 5 Oligometastases: An Analysis From the Population-Based Phase 2 SABR-5 Trial.
Int J Radiat Oncol Biol Phys
; 114(4): 617-626, 2022 11 15.
Article
in En
| MEDLINE
| ID: mdl-35667528
Full text:
1
Collection:
01-internacional
Health context:
1_ASSA2030
/
2_ODS3
Database:
MEDLINE
Main subject:
Radiosurgery
/
Neoplasms
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
Int J Radiat Oncol Biol Phys
Year:
2022
Document type:
Article